Thursday, February 28, 2013

Japan "best market in the world" for foreign drugmakers

Japan "best market in the world" for foreign drugmakers
Japan is enjoying the benefits of changing the way it reviews, administers and pays for drugs in an effort to spur innovation and address rising costs associated with aging. "For foreign [drug] companies, it's the best market in the world right now," PhRMA representative Ira Wolf said. The country has accelerated the review of new treatments, placed the pricing system under review and set a 30% market share goal for generics. The Economist (tiered subscription model)(2/22) LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Update account information |Change e-mail address |Unsubscribe |Print friendly format |Web version |Search past news |Archive |Privacy policy

Account Director, Life Sciences: Meryl Harold (202) 407-7828
Read more
Recent DIA Global SmartBrief Issues: Lead Editor: Lisa Gough

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information

No comments:

Post a Comment